 |
 |
Dear Pam - VERY many thanks for this - and for reminding me of that web site. I have passed this to my enquirer. Incidentally, you may all be amused to know that a leading cancer organisation - whose manager lost her post not so very long ago - gave me a response of breath-taking unhelpfulness, coupled with the advice that I may wish to check with my library - and giving a location which is 16 years out of date!!! Fiona - if you're reading this - I, at least, sorely missed you!! Pam - thank you again. Zena Woodley B.A.(Joint Hons), MCLIP ~ Library Resources Manager ~ The Warner Library, Broomfield Hospital, Chelmsford CM1 7ET T: 0844 8220002ext 4310 e: [log in to unmask]<mailto:[log in to unmask]> Ask an Information Expert - it's what we do. All day. Every day. -----Original Message----- From: White, Pam [mailto:[log in to unmask]] Sent: 09 June 2008 15:39 To: Woodley Zena (RQ8) Mid Essex Hospital; [log in to unmask] Subject: RE: Capecitabine long-term trial Hi Zena, I am replying to all of lis-medical because the website, www.clinicaltrials.gov<http://www.clinicaltrials.gov>, may be of interest to anyone seeking information on clinical trials. A fairly quick and dirty search on capecitabine AND Spain AND breast AND neoplasms[conditions] came up with the following results: http://tinyurl.com/43mlzg Hope this helps, Pam Pam White, Library Services Manager Dorset County Hospital NHS Foundation Trust 01305 255 764 http://www.dchft.nhs.uk/patients/wards-depts/library/index.html ________________________________ From: UK medical/ health care library community / information workers [mailto:[log in to unmask]] On Behalf Of Woodley Zena (RQ8) Mid Essex Hospital Sent: 09 June 2008 15:08 To: [log in to unmask] Subject: Capecitabine long-term trial Hello everyone, on this beautiful summer's day - I have a puzzle, which is this: Our enquirer has a reference from the Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol.24, No. 18S (June 20 Supplement), 2006:10755. This concerns a trial in Spanish hospitals of the "safety of long-term administration of capecitabine in metastatic breast cancer patients". The conclusion states it is preliminary data; and my enquirer wants to know the progress of the trial. Irritatingly, no direct author email addresses are given. Is there any way, other than contacting the named hospitals (and hoping the named authors are still there), of ascertaining this? Is there a European equivalent of Cochrane? Any information gratefully received! Many thanks - Zena Zena Woodley B.A.(Joint Hons), MCLIP ~ Library Resources Manager ~ The Warner Library, Broomfield Hospital, Chelmsford CM1 7ET T: 0844 8220002ext 4310 e: [log in to unmask] Ask an Information Expert - it's what we do. All day. Every day. Foundation Trust application - have your say! Mid Essex Hospital Trust is applying to become a Foundation Trust. We are therefore approaching local people, patients and staff to seek their views about our proposed governance arrangements and to ensure that we provide services that respond to the needs of the local community. As part of this process, we want you to become a member of Mid Essex Hospital Trust. As a member you have a wonderful opportunity to get involved and shape the future of your hospital for the next 20 years. You can apply for membership online at: http://www.meht.nhs.uk/foundation-trust/apply-online/. Alternatively, you can request a membership application form by e-mailing [log in to unmask], by calling: 01245 514508 (during office hours) or by writing to Foundation Trust Office, Broomfield Hospital, Chelmsford, CM1 7ET. Information in this message may contain confidential and privileged information. If you are not the intended recipient please accept our apologies; please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents: to do so is strictly prohibited and may be unlawful. Please inform us that this message has gone astray before deleting it. Content of emails received by this Trust will be subject to disclosure under the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, confidentiality of this e-mail and your reply cannot be guaranteed. Thank you for your co-operation.